Introduction
============

Whole-genome sequencing along with decades worth of detailed biochemical and enzymatic data (e.g., bibliomic data) on microbial metabolism has led to the reconstruction of metabolic networks at the genome scale (so-called, GENREs or genome-scale reconstructions; [@b92]; [@b30]; [@b41]; [@b116]). Integrating this information in a structured fashion has enabled its translation into computational models that can be used to calculate metabolic phenotypes ([@b85]; [@b88]; [@b67]). In addition, other omics data types that have been generated can be interpreted in the context of a reconstruction and computational model to analyze cellular functions under specific conditions. Taken together, this information becomes a *de facto* knowledge base. Genome-scale models (GEMs) are a structured format of such a knowledge base that can be used to perform computational and quantitative queries to answer various questions about the capabilities of organisms and their likely phenotypic states ([@b84]; [@b78]).

*Escherichia coli* is one of the most important model organisms in biology and its metabolic GEM has aided the development of microbial systems biology. The history of the metabolic network reconstruction process for *E. coli*, and the formulation and testing of its metabolic GEM now spans over a decade ([Figure 1](#f1){ref-type="fig"}). One of the earliest studies to systematically analyze *E. coli* utilized a simplified constraint-based model of acetate overflow ([@b70]). Subsequent pre-genome-scale studies expanded upon the constraint-based approach to include reactions involved in central carbohydrate metabolism, amino acid synthesis, and nucleotide synthesis to evaluate the biocatalyst production potential of *E. coli* ([@b118]; [@b121]) using flux balance analysis (FBA; [@b119]). The ability of FBA, in particular, and constraint-based modeling, in general, to quantitatively describe the metabolic physiology of *E. coli* observed experimentally ([@b120]) arguably solidified the value of systems level analysis in understanding microbial metabolism. The sequencing of the *E. coli* genome ([@b13]), the advent of the lambda-red system for efficient genome manipulation ([@b25]), and information readily available on annotated content of *E. coli* in databases and detailed biochemical reviews led to a steady increase in content of the *E. coli* GEM in the genomic era. Reconstruction efforts in the 2000s built off of successive versions, each adding new subsystems (e.g., fatty acid, alternate carbon metabolism, and cell wall synthesis, respectively) as the reconstructions strived to incorporate all of the existing content in literature and newly appearing data. Analysis of the rate at which new content was added to the latest metabolic GEM ([@b77]) indicates that mostly newly characterized content is now left to include in the reconstruction. Future expansion for the metabolic GEM is likely to come from characterizing promiscuity of known enzymes, and the addition of protein synthesis will open the door for more detailed examination of other cellular processes and integration with other omics data sets.

In over a decade of model-driven development of systems biology for *E. coli*, over 200 peer-reviewed studies have appeared, as summarized in [Figure 2](#f2){ref-type="fig"} and [Supplementary Figure S1](#S1){ref-type="supplementary-material"}, and as documented in greater detail in [Supplementary Table S1](#S1){ref-type="supplementary-material"}. This review aims to determine the benefits and drawbacks of the uses of the *E. coli* GEM to date, what has been accomplished, what has been missed, and what is likely to lie ahead for this field in its next decade of development.

Categories of uses of GEMs
==========================

The *E. coli* GEM has been applied to answer different biological questions ([Figure 3](#f3){ref-type="fig"}), most frequently in the categories of (1) metabolic engineering, (2) model-driven discovery, (3) prediction of cellular phenotypes, (4) analysis of biological network properties, (5) studies of evolutionary processes, and (6) models of interspecies interactions. In a previous review we described and categorized the uses of the *E. coli* GEM appearing in 64 papers published before 2007 ([@b31]). Similarly, [@b76] have reviewed applications enabled by GEMs for organisms other than *E. coli* through 2009, and specific reviews on GEM-enabled studies in plants ([@b111]) and *Saccharomyces cerevisiae* ([@b79]) have recently appeared. However, the *E. coli* GEM remains the oldest and arguably the most extensively utilized GEM, and given the extensive uses of the *E. coli* GEM that have appeared since 2007, we now have a sufficient amount of studies to critically assess what GEMs can and cannot do by focusing on the *E. coli* GEM as a subject. For example, metabolic engineering and model-driven discovery are categories of uses in *E. coli* that have matured over the years into workflows that can be continuously repeated to tackle a diverse set of biological questions. In particular, strain design has matured from academic to industrial; thanks to the advent of sustainable processes that can be applied from one target compound to another. The development of these iterative workflows in systems biology is a theme that will be highlighted and discussed in greater detail as they appear in each category. In another example, recent studies modeling interspecies interactions signal an expansion of the field from single cell models to ecosystem level models. We have also highlighted a collection of noteworthy studies ([Supplementary Figure S2](#S1){ref-type="supplementary-material"}) from the pool of uses that, we feel, demonstrate how a GEM can be well utilized to deduce biological complexities.

A detailed overview of the successes and limitations of the *E. coli* GEM implementation for the categories outlined above have been summarized in [Table I](#t1){ref-type="table"} and will be presented in detail in each section below. At the conclusion of each section, we will then assess how the limitations of GEMs can be overcome with further development and refinement. We also highlight systems biology workflows made possible by GEMs. Furthermore, we will attempt to identify the future challenges that need to be overcome to bring us closer to the ultimate goal of establishing a comprehensive and multi-scale mechanistic understanding of the genotype--phenotype relationship of microbial metabolism. It should be stressed that although this review is focused on the *E. coli* GEM, the findings documented here can be readily extended to metabolic modeling at the genome scale in general.

Metabolic engineering
---------------------

Current industrial processes rely upon nonrenewable resources that cannot sustain the growing world population indefinitely. The development of biosustainable processes that can convert renewable resources into commodity items is therefore of paramount socio-economic importance. Bacteria have recently emerged as a means by which to achieve bio sustainability ([@b63]). Through metabolic engineering, the native biochemical pathways of bacteria can be manipulated and optimized to more efficiently produce industrial and therapeutically relevant compounds. The *E. coli* GEM has guided metabolic engineers towards the production of an assortment of compounds, including organic acids, amino acids, and alcohols to name a few (see [Supplementary Table S3](#S1){ref-type="supplementary-material"} for a comprehensive list).

Contrary to random mutagenesis and screening, rational strain design uses the GEM to predict cellular phenotypes from a systems level using genomic, stoichiometric, kinetic, and regulatory knowledge to identify engineering strategies, which can then be implemented *in vivo*. These strategies include gene deletions ([@b34]), gene over- and underexpression ([@b36]), mapping high-throughput data onto the network reconstruction to identify bottlenecks or competing pathways ([@b64]), and more recently, integration of nonnative pathways into standard microbial production hosts for production of compounds that are either not natively found in, or only synthesized in minute concentrations by the host ([@b50]; [@b127]; [@b129]). More advanced methods have even allowed for the identification of strategies that couple bacterial growth to target product overproduction ([@b14]; [@b86]; [@b53]). A so-called 'growth-coupled\' strain leads to a more robust strain that is less likely to lose the genetically engineered genotype, or be outcompeted by alternate bacterial phenotypes in a bioprocess environment. A cadre of algorithms, first appearing in 2003 ([@b14]), with increasing biological detail ([@b53]) or alternative optimization methods ([@b86]) have been developed ([Supplementary Table S2](#S1){ref-type="supplementary-material"}) and extensively reviewed ([@b76]; [@b23]).

Engineering strategies found using model-driven analysis can often be nonintuitive and highlight some of the most interesting recent findings using GEMs. For instance, researchers used the GEM to not only determine a gene that needed to be upregulated, but were able to tune the expression level of this gene after subsequent GEM analysis of a deleterious overexpression event ([@b64]). In another GEM-enabled study, the highest flavanone production was predicted and experimentally determined by strategically knocking out genes to not only increase the production of the redox carrier (NADPH) to drive the heterologous flavanone catalyst, but also to maintain the optimal redox potential of the cell (i.e., the ratio of NADPH to NADP^+^) ([@b36]; [@b17]). For a final example, researchers improved the production potential of the nonnative metabolite 1,4-butanediol in *E. coli* by over three orders of magnitude ([@b129]). The researchers were able to rewire the host cell to produce the compound via native and nonnative pathways by ensuring that the production of 1,4-butanediol was the only means by which the host cell could maintain a redox balance and grow anaerobically ([@b129]). These successes highlight the need to analyze genetic alterations at the systems level where one can not only predict the activation of pathways that compensate for lost functionalities following gene deletions, but also predict engineering strategies that couple cellular goals to target compound overproduction.

Engineering strategies derived from the *E. coli* GEM have also led to nonviable and suboptimal phenotypes. Even in the above studies ([@b36]; [@b17]; [@b129]), the authors had to carefully select which predicted knockout designs were constructed *in vivo*, due to, e.g., known isozymes that result in nonviability when deleted simultaneously. Hence, a strong understanding of metabolic biochemistry is a prerequisite for successful strain design. Many potential engineering strategies cannot be addressed with the current generation of GEMs as they do not account for translational regulation and detailed enzyme kinetics. For example, strains generated using random knockouts via transposon libraries and screening for lycopene overproduction identified gene deletion targets in regulatory elements ([@b4]) that cannot be predicted by the current GEM. Similarly, as GEM does not account for optimal codon usage, the *in vivo* performance of nonnative genes and proteins cannot be predicted.

The *E. coli* GEM has tilted the field of metabolic engineering towards advanced rational strain design by enabling researchers to explore a vast native and nonnative genetic space in designing strains for improved metabolite production. More complete biochemical information will greatly aid metabolic engineering by allowing for genome-scale reconstructions that account for cellular functions beyond those accounted for in the metabolic models (e.g., regulation, expression, and enzyme kinetics). This implies the need for greater experimental method development to deduce the details of expression, posttranscriptional and posttranslational modifications, and enzyme kinetics. Advancements in pathway finding procedures to identify heterologous pathways that are not native to the host, and the techniques to optimize the expression of nonnative enzymes will expand the type of compounds that can be overproduced at an industrial scale. Overall, the ability of the *E. coli* GEM to aid systems level analysis for rational strain design will only continue to improve the speed with which viable production strains can be designed and constructed.

Biological discovery
--------------------

There are aspects of bacterial functions that remain uncharacterized. Even in *E. coli*, the most studied and best-known bacterium, 34% of the genes have an unknown function ([@b77]). In order to more efficiently expand our current understanding of cellular functions, an iterative workflow is needed that allows researchers to (1) account for what is known, (2) identify gaps in our knowledge, and (3) allow for the design of experiments to elucidate these gaps. The *E. coli* GEM has enabled the implementation of such a workflow to discover new features of microbial metabolism ([Supplementary Table S4](#S1){ref-type="supplementary-material"}).

The function of uncharacterized open reading frames (ORFs) can be elucidated by comparing growth phenotypes from *in silico* model predictions of gene deletion mutants to *in vivo* experimental data ([Box 1](#bx1){ref-type="boxed-text"}). Discrepancies between GEM predictions and experimental results can point to where current knowledge is missing or where there are functional discrepancies. This, in turn, allows one to systematically formulate testable hypotheses. For example, incorrect predictions made for *talAB* mutants grown on xylose led the authors to discover a novel pathway catalyzed by the gene products of *pfkA* and *fbaA* ([@b73]). Various algorithms have been implemented to aid researchers in this process by parsing the vast number of biochemical pathways of metabolism to reconcile *in silico* growth predictions with experimental data ([@b95]; [@b99]; [@b7]). These algorithms suggest network modifications (including assignment of enzymatic function to uncharacterized ORFs) that can then be confirmed by researchers *in vivo* ([@b95]). For example, one study used a combination of graph-theory-based and comparative genomic analyses to identify *yneI* (*sad*) as the gene responsible for the NAD^+^/NADP^+^-dependent succinate semialdehyde dehydrogenase, which the authors experimentally confirmed ([@b37]).

Although the GEM-enabled workflow ([@b24]; [@b48]; [@b95]; [@b7]; [@b44]) has advanced our understanding of metabolism greatly, many aspects of bacterial metabolism are still waiting to be uncovered. One such aspect is the transcriptional regulation of metabolism. Researchers have attempted to integrate the transcriptional regulatory network (TRN) with the metabolic network to better understand and predict regulation. For example, the TRN was used to elucidate changes in expression of oxygen regulators between oxic and anoxic conditions ([@b24]). In another example, the TRN was used to confirm and refine the regulatory and functional assignment of various regulatory and metabolic genes, which included the novel finding that [D]{.smallcaps}-allose induces *rpiR* ([@b7]). However, the Boolean formulation of the TRN regulatory rules only allows one to model regulatory interactions as either on or off. Consequently, complex regulatory interactions involving a multitude of transcription factors, binding constants, and environmental dependencies along with posttranscriptional and posttranslational modifications that may account for *in silico* and *in vivo* discrepancies cannot be identified using the current GEMs.

Efforts are underway to better understand bacterial regulation. Large-scale, genome-wide screens to deduce the function of transcriptional regulators and the development of new formalisms to account for and integrate transcriptional regulation in the model are in progress ([@b19]). RNA sequencing-based technology will greatly assist researchers in elucidating the interactions of the transcriptional network by providing a richer data set than the existing methods (e.g., RNA microarrays and ChIP-chip; [@b19]). Other posttranscriptional and posttranslational modifications (these include, for instance, by small RNA at the transcript level or by phosphorylation, methylation, glycosylation, acetylation, or carboxylation, to name several, at the protein level) also contribute to the regulation of metabolic function in prokaryotes. Exemplary experimental efforts to better understand small RNA regulation of transcription ([@b124]), and the conservation of phosphorylation in serine, tyrosine, and threonine metabolism ([@b69]) have demonstrated that the link between gene expression and metabolite profiles are far more complex than once thought. Continued experimental efforts and improved computational efforts to deduce and model the complexities of regulation will be needed to expand the scope of biological discoveries that the current model can assist with.

Phenotypic functions
--------------------

For simple organisms, the physiology of bacteria is remarkably complex. The diverse set of biochemical pathways in bacteria have conferred a vast phenotypic potential that have enabled them to thrive in a plethora of environments ranging from volcanic vents on the bottom of the ocean, clouds, glaciers, and the human gut. In order to understand this phenotypic potential, researchers have turned to GEMs to interpret and predict cellular phenotypes. Constraint-based modeling with GEMs ([@b84]) has allowed researchers to rapidly predict growth phenotypes in various genetic ([@b35]) and environmental ([@b45]) conditions, explore different objectives of microbial metabolism ([@b101]; [@b80]) to examine the driving force behind cellular function, and better understand the suboptimal behavior of cells following perturbation ([@b104]; [@b68]) and latent pathway activation ([@b74]).

When phenotypic predictions are made using the GEM, one finds a large solution space of potential phenotypes that would allow the organism to survive in a given genetic and environmental background. Many of these solutions of metabolic network usage that would allow for survival may not be observed under physiological conditions. Consequently, researchers have formulated ways to confine the solution space to more accurately represent the experimentally observed phenotype of the cell for a given growth condition by incorporating constraints. Regulatory control of the metabolic genes provides a means to constrain the allowable solution space by specifying what genes are active in the metabolic network for a given environmental condition. Researchers have been able to show that while over 50% of the flux distribution is constrained by metabolism in a given environmental condition, an additional 20% can be attributed to the TRN ([@b107]). In addition, the TRN allows the organism to rapidly and efficiently adapt its metabolism to a wide range of environmental conditions by altering the expressed metabolic genes ([@b6]; [@b96]). Spatial constraints in the form of molecular crowding ([@b11]; [@b122]), growth-associated metabolite dilution ([@b12]), membrane occupancy ([@b134]), super coiling of the DNA ([@b109]), and indirect protein--protein interactions to facilitate the organization of enzymes in the cytoplasm ([@b87]) have shown promise for increasing the predictive power of the *E. coli* GEMs. For instance, a mechanistic constraint on the available space on the cytoplasmic membrane was introduced to better explain respiro-fermentation physiology ([@b134]). Researchers have also shown that the physical structure of the DNA correlates more closely to the metabolic state than the regulatory network ([@b109]). Thermodynamic analysis provides another means to constrain the solution space by removing infeasible reaction loops that violate energy balance ([@b27]; [@b33]), by refining reaction directionality, and by defining allowable flux ranges via calculation of the *in vivo* change of Gibbs free energy of reactions ([@b59]; [@b40]; [@b32]). Intimately tied to thermodynamic analysis is the integration of high-throughput metabolomics data. Several studies have incorporated metabolomics data into the *E. coli* GEM to better calculate the *in vivo* change in Gibbs free energy of reaction in order to better confine the feasible flux range of reactions and identify reactions that are potentially under allosteric regulation ([@b132]; [@b130]).

The metabolic model can be used as a scaffold onto which high-throughput data types, such as fluxomic ([@b42]; [@b20]; [@b18]), transcriptomic ([@b10]; [@b90]), and proteomic data ([@b66]), can be mapped to gain insight into context-specific phenotypes. Fluxomics data can be used to directly compare intracellular flux distribution as predicted by constraint-based models ([@b42]; [@b18]) using the GEM and can even be incorporated as additional constraints ([@b20]). Recent work has also demonstrated that fluxomic data can be integrated into a computational framework to explain suboptimal behavior as a trade-off between near optimal growth under one condition, and the ability to quickly adapt to a new growth condition ([@b102]). Transcriptomic data provide the experimentalist with a powerful means to decipher the phenotypic behavior of the cell due to its ability to qualitatively or quantitatively determine what genes are expressed by the cell under the given experimental conditions ([@b90]). A combination of transcriptomic and proteomic data have also allowed researchers to better understand the physiology of adapted strains and the mechanism for this adaption ([@b66]).

Although the *E. coli* GEM has aided our understanding of cellular metabolism, it has limitations. For instance, one should be aware that alternate optimal flux distributions of the cell may confound the researcher\'s ability to determine the true physiological state. This has been demonstrated when comparing fluxomic data to *in silico* predictions ([@b18]) and also in studies of adapted *E. coli* mutants ([@b35]; [@b16]) where variations found in evolved replicates reflected the possible existence of multiple flux distributions that lead to equivalent growth phenotypes. The methods to predict cellular physiology present a user bias in the form of an objective function that must be validated for specific growth conditions ([@b101]). The suboptimal state of the cell can also be predicted, but the most utilized method ([@b104]) provides little insight into the biological driving force for suboptimal performance ([@b106]). It appears instead that a Pareto optimal solution of multiple (and at times) conflicting objectives can better explain the biological significance of suboptimal behavior than any one method ([@b102]). Incorporating thermodynamic constraints has been demonstrated to greatly reduce the solution space of metabolism. Unfortunately, the calculation of Gibbs free energy of reaction is hampered by the limited availability of experimentally determined standard Gibbs free energy of formation for a majority of the metabolites in the *E. coli* GEM. Therefore, the free energies of reaction can only be estimated ([@b47]).

Advancements in methods to obtain and integrate high-quality omics data with the model will aid in overcoming many current limitations in accurately predicting phenotypic behavior. For example, genome-scale metabolomics is hampered by the biochemical diversity, range of physiological concentrations, and chemical liability of the species that comprise the intracellular metabolome. Consequently, multiple analytical platforms and well-tested analytical procedures ([@b15]) are needed to accurately assay the full metabolome, which is costly, time-consuming, and technically challenging. The enzyme kinetic and thermodynamic information that can be obtained from metabolomics can directly improve the accuracy of the metabolic model, and can also be correlated with gene expression profiles ([@b49]) to assist in unraveling the dynamics between transcriptome and metabolome. Another promising area is the formulation of a genome--scale isotope mapping model ([@b93]) for implementation with metabolic flux analysis. An expansion of metabolic flux analysis to the genome--scale and the ability to determine the intracellular distribution of atoms beyond carbon will enhance our knowledge of *in vivo* flux states.

Biological network analysis
---------------------------

The metabolic reaction network is a highly complex, interwoven, and nonlinear system that responds to environmental and genetic perturbations. In order to elucidate and understand the relationship between the network structure and function, many researchers have turned to network analysis. This exercise is mathematical in nature. In network analysis, biochemical reactions are transformed into a unipartite or bipartite graph, where the nodes and links take the form of metabolites and enzymatic reactions. Once formulated as a graph, the network can be sampled and explored using a variety of minimally biased mathematical and algorithmic methods to arrive at biologically insightful conclusions. The following paragraphs will focus on the most recent advances in biological network analysis; the reader is referenced to [@b31] and [@b76] for less recent examples not covered in the main text.

Much progress has been made in the analysis of link and node essentiality, whereby the consequences of removing a link (i.e., the reaction) from the network is examined. As links have varying degrees of dependence upon one another, one must look to higher-order combinations of link removals to better understand the network properties of the *E. coli* GEMs. For example, synthetic lethals, which are defined as two genes whose independent deletion is not lethal, but simultaneous elimination is lethal, are often a consequence of network redundancy or parallel pathways ([@b38]). The converse of synthetic lethals, synthetic rescues, which are defined as a gene pair where the deletion of one of the genes is lethal, but the simultaneous deletion of both genes is nonlethal, can be used to rescue a nonviable single-gene deletion phenotype by rewiring the network in such a way as to compensate for the deleterious effect of the initial genetic perturbation ([@b72]; [@b52]). To illustrate, it has been shown that the overexpression of *udhA* improves the growth of *E. coli pgi* knockout strains on glucose minimal media ([@b52]). Higher-order epistatic interactions have also been analyzed to predict nonintuitive combinations of lethal and auxotrophic-inducing/rescuing gene deletions ([@b110]).

It is important to emphasize that although the *E. coli* metabolic network is analogous to other interaction networks (e.g., the internet) and can be interrogated using network theory ([@b3]; [@b98]), the *E. coli* network is unique in that it is a biological network that describes a highly evolved function. Network analysis can easily be taken out of context or provide little insight if the function of the metabolic network is not taken into account. For example, graph theory can deduce the topological properties of the model without providing any information about the underlying biology. A prerequisite of biologically meaningful network analysis is a biologically functional random network, to which one can compare the properties of the *E. coli* GEM ([@b97]; [@b8]). However, the *in vivo* experimental validation of such comparisons (i.e., to a random network) is infeasible. In addition, many of the network analysis methods become computationally challenged for large biochemical networks. Examples include elementary mode ([@b103]) and extreme pathway analyses ([@b100]), which have been, for the most part, limited to small-scale networks due to the combinatorial explosion inherent to the methods ([@b55]; [@b128]). It should be noted that numerical efforts have been made to scale pathway analysis to GEMs by calculating only a subset of elementary modes ([@b125]). In addition, the *E. coli* metabolic network model is subject to iterative updates. Analyses obtained between older and newer models can lead to vastly different results. For instance, 81% of the coupling relations identified using flux coupling analysis changed between *i*JR904 and *i*AF1260 due to missing reactions in the older network model ([@b71]).

Network analysis using GEMs has largely been depicted as a strictly *in silico* undertaking. Recent progress, however, indicates that network analysis has practical applications. For example, the recent advances in elementary mode analysis can be readily extended to strain design ([@b26]) and nonnative pathway finding procedures ([@b60]). In another example, progress has been made in applying network analysis of the *E. coli* metabolic GEM to discover novel drug targets ([@b89]; [@b54]; [@b105]). The *E. coli* GEM is particularly suitable for this application by enabling pharmaceutical researchers to analyze the complex interactions of the network as a whole, to elucidate target links and nodes that would allow for complete system collapse or would severely cripple the network if removed. A potential viable workflow for antimicrobial drug discovery was recently presented ([@b105]). The workflow invoked network analysis to identify novel antimicrobial targets combined with computational screening to identify inhibitory molecules against them followed by experimental validation ([@b105]). This GEM-aided workflow could reduce the expensive and time-consuming experimental methods in drug discovery ([@b105]), and is readily extendible to other bacterial species.

Bacterial evolution
-------------------

The genomic content and phenotypic landscape of bacterial species are constantly adapting to meet the demands of the imposed environmental conditions. Adaption occurs via elimination of individual reactions by loss-of-function mutations, alterations in gene expression and enzyme capacity, alterations in enzyme kinetics, and through the addition of new reactions by horizontal gene transfer, gene duplication, and gain-of-function mutations. The *E. coli* GEM has been proven to be most useful in modeling microbial evolution through elimination and addition of new metabolic network content, and acting as a scaffold to aid in the understanding of bacterial evolution.

Computational frameworks using GEMs have been employed to simulate bacterial evolution through random gene deletions. These studies have shown that there appears to be a conserved reaction set that is similar for organisms with similar lifestyles ([@b83]), which reflects the common enzymatic machinery required to metabolize specific carbon sources. It has also been shown that although genes are lost at random, the order in which genes are lost follows a coordinated and consistent pattern---40% of which can be accounted for by the metabolic model when compared with available phylogenic data ([@b131]). The *E. coli* GEM also provides a context by which phylogeny data can be understood. Comparative genomics in the context of constraint-based modeling with the *E. coli* GEM has led researchers to assert that the dominant mechanism of bacterial evolution in *E. coli* appears to be horizontal gene transfer. Horizontal gene transfer is highly dependent upon the genomic content of the organism ([@b82]; [@b75]) and involves genes that are mostly environment-specific and located at the periphery of the metabolic network ([@b81]).

The *E. coli* GEM can act as a scaffold on which similar bacterial strains can be reconstructed, and their divergent evolutions understood. Because of the high standard of biochemical accuracy of the *E. coli* metabolic GEM (e.g., 97% of the included genetic content of the most recent *E. coli* GEM has been experimentally validated ([@b77]), many researchers have based the reconstruction of specific pathways or the entire organism on the reactions of the *E. coli* GEM (e.g., *Salmonella typhimurium* ; [@b1]). More recently, the pangenome of the species *E. coli* was reconstructed based on *i*AF1260, and was used to generate five strain-specific GEMs that include commensal strain K-12 W3110, two enterohemorrhagic O157:H7 strains EDL933 and Sakai, and two uropathogenic strains CFT073 and UTI89 ([@b9]). The study found that pathogenic *E. coli* appear to be more adapted to growth under anaerobic conditions than commensal *E. coli* ([@b9]). The use of the *E. coli* GEM to rapidly construct strain-specific models will continue to increase, particularly as the cost of genome sequencing of microbes continues to fall and the available number of sequenced and annotated strains continues to rise.

Although the metabolic model allows a vast region of genotypic space to be explored in order to model and understand bacterial evolution, the space is currently limited to metabolic genes. Changes in the regulation of metabolism during evolution are not accounted for in GEMs. Although horizontal gene transfer and gene loss can be modeled up to the resolution of a core metabolic gene set ([@b83]), and the predicted gene-loss order can be compared with evidence provided by comparative genomics ([@b131]), limitations remain in determining the precise genes and their exact loss, the location of mutations in the genome, and predicting their effect on the physiology of the organism. In addition, comparison of the evolutionary trajectories of different bacterial strains is hampered by the fact that strain-specific portions of the genomes remain largely uncharacterized.

The use of GEMs in modeling and understanding bacterial evolution will benefit from studies of adaptive laboratory evolution (ALE). ALE is an experimental procedure that introduces a selection pressure (e.g., fastest growth) in a controlled environmental setting that allows for a time-resolved depiction of changes in the organism\'s genome that occur during the process of adaption ([@b22]). These changes can then be reintroduced and their effect on the organism\'s fitness studied ([@b43]; [@b21]; [@b62]; [@b5]). The GEM provides a context for understanding these mutations by allowing the researcher to model the growth physiology of the adapted network.

Interspecies interaction
------------------------

There is a growing interest in better understanding host--pathogen interactions for the development of improved antimicrobials ([@b61]), the use of microbes for environmental remediation ([@b108]), and for understanding and manipulating the microbiome of the human gut for improved health ([@b123]). Such applications would benefit greatly from a platform that would allow for the prediction and simulation of biological interactions. The *E. coli* GEM provides such a platform and has been successful in modeling the exchange of metabolites ([Box 2](#bx2){ref-type="boxed-text"}) between different cell types (e.g., microbial species) and environmental conditions ([@b46]; [@b56]; [@b126]).

Although interaction classes of interspecies interactions have been established, the mathematical formalism to model these interaction classes using GEMs has arisen only recently ([@b46]; [@b56]; [@b126]; [@b39]; [@b117]). Researchers have modeled host--pathogen interactions by directly incorporating pathogenic reactions into the stoichiometry of the host reaction network (e.g., to account for viral amino acid and nucleotide synthesis ([@b46]). Concatenated and joint stoichiometric models have been employed to study the exchange of metabolites between species (e.g., cocultures; [@b126]; [@b39]) and the environment ([@b56]). In contrast to multicellular stoichiometric models, which assume that the collection of microbes seeks to maximize the collective biomass, researchers have developed multicompetitor metabolic models to describe microbial communities, where each member seeks to maximize their own biomass ([@b117]). Together, these studies have found that the combined metabolisms of multiple species can utilize the capabilities of the environment better than a single species. Furthermore, although not every metabolic interaction is beneficial, metabolic interactions necessitate community formation.

Much work remains in the field of modeling interspecies interactions. For example, the measurement of metabolites exchanged between cells, needed to validate the accuracy of the *in silico* predictions, presents a strong technical challenge. In addition, the effect of biological interactions on regulatory elements is not yet accounted for. For instance, the extent to which other strains and the environment influence the regulation of metabolism (e.g., through quorum sensing) is unclear. Moreover, most of the large-community models do not differentiate the genetic content between individual species nor account for their spatial organization. Consideration of regulation, individual genetic content, and spatial organization will be needed to more accurately model and predict community-level biological processes ([@b133]).

The advent of single-cell sequencing technology ([@b112]) and other single-cell assays ([@b113]) will benefit the study of interspecies interactions with GEMs. Such a 'bottom-up\' approach would allow for the characterization of individual biological entities through, e.g., genomics and transcriptomics of individual species. From a 'top-down\' approach, the total interaction of microbial communities can be characterized through genome-scale omic data. Genome sequencing and reconstruction of other bacterial species through manual curation or automatic reconstruction (e.g., model SEED; [@b41]), and the mapping of metabolite and reaction identifiers between reconstructions (e.g., RxnMet ([@b58])) will expand the number of species interactions that can be simulated together. On the basis of the genome-scale omic data that correspond with single cell data, developments in bioinformatics approaches that establish the relationships between individual biological entities and the growing number of reconstructions will allow researchers to piece together the contribution of each member on the biological community in order to generate complete community-level models.

In closing: what is likely for the future of GEMs
=================================================

The number of applications focused on *E. coli* that have utilized the metabolic GEM have grown in size and scope ([@b31]). This review distilled into six categories the ∼200 studies that have appeared in peer-reviewed manuscripts over the past 12 years. In each category, key examples and success stories were summarized and presented. In addition, we critically analyzed the current status of applications using the *E. coli* metabolic GEM to demonstrate what the model can and cannot do, and discussed the developments needed to overcome current limitations, as summarized in [Table I](#t1){ref-type="table"}. To help summarize the impact of GEM-aided analyses thus far, [Supplementary Figure S2](#S1){ref-type="supplementary-material"} highlights studies that have made a significant contribution to the *E. coli* GEM in particular, and our understanding of microbial metabolism, in general. Researchers are now able to complete the systems biology workflow and generate new biological knowledge with the help of the *E. coli* GEM ([Figure 4](#f4){ref-type="fig"}). It should be emphasized that although this review has focused on the metabolic network, it is but one of several networks actively at work inside the cell ([@b30]).

The GEM of *E. coli* will continue to expand, as more cellular processes are mechanistically detailed and added to the organized GEM structure. The next significant increase in the applications of an *E. coli* GEM will likely come from mechanistically incorporating and integrating protein synthesis with metabolism. The integration of the transcriptional and translational machinery on the genome scale ([@b115], [@b114]) has now been completed. The operon structure that accounts for cellular regulation will follow protein synthesis as the next logical step of GEM expansion. The incorporation of DNA structure and transcription binding as a ready-to-compute biochemical network in a mathematical format would overcome the limitations presented by the current Boolean formulation of the TRN, and allow for complex regulatory interactions to be mechanistically modeled and predicted. It is conceivable that DNA synthesis, posttranslational modifications, and other cellular processes that involve biochemical interactions that can be described by a biochemical interaction network can also be incorporated into GEMs. In brief, what lies ahead for GEMs is the iterative expansion to include other cellular processes beyond metabolism, with the aid of omics data and the mathematical formalisms to model them ([Figure 5](#f5){ref-type="fig"}). It is unclear which high-throughput data types and algorithms will be the major drivers for many of the applications enabled by GEMs with an expanded scope. However, it is clear that modeling with such expansive networks, whose components will carry activities across many orders of magnitude, will require greater computational accuracy and power given their size. Furthermore, the payoff for this increased complexity will be more accurate phenotype predictions after initial validation and gap filling is performed. GEM expansion will be a substantial but worthwhile endeavor that will unite many diverse aspects of microbiology and move the community closer to the ultimate goal of establishing a comprehensive mechanistic understanding of the genotype--phenotype relationship of microbes.
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![History of the *E. coli* expression and metabolic reconstructions. Shown in the upper portion of the graph are 2 milestone efforts contributing to the reconstruction of the *E. coli* transcription and translation network, and shown in the bottom portion of the graph are 7 milestone efforts contributing to the reconstruction of the *E. coli* metabolic network. For each of the two reconstructions shown ([@b2]; [@b115]) in the upper graph, the number of included transcription units (blue diamonds), genes (green triangles) and components (purple squares) are displayed. For each of the seven reconstructions shown ([@b70]; [@b121]; [@b91]; [@b28]; [@b94]; [@b29]; [@b77]) in the bottom graph, the number of included reactions (blue diamonds), genes (green triangles) and metabolites (purple squares) are displayed. Moreover, listed is noteworthy content expansion that each successive reconstruction provided over previous efforts. For example, [@b118], and [@b121] included amino acid and nucleotide biosynthesis pathways in addition to the content that [@b70] characterized. The start of the genomic era ([@b13]) marked a significant increase in included components for successive iterations of the network reconstruction. The significant increase in the number of reactions in 2007 ([@b29]) was, in large part, due to the removal of many lumped reactions, which were often included for lipid and cell wall biosynthesis in earlier metabolic reconstructions. [@b115] expanded the initial work of [@b2] by increasing the scope of the transcription and translation network from a few example pathways to all known genes involved in protein synthesis (i.e., expression). Not included on the timeline is a metabolic reconstruction based upon [@b94], which was modified to include additional reactions from the KEGG ([@b51]) database and incorporated into the MetaFluxNet software package ([@b65]).](msb201318-f1){#f1}

![The detailed usage of the *E. coli* metabolic GEM over time. The cumulative and new number of studies published per year separated according to (**A**) the metabolic reconstruction used ([@b28]; [@b94]; [@b29]; [@b77]), (**B**) *in silico* (i.e., strictly computational prediction) or combined *in silico* and *in vivo* (i.e., computational usage of the model and experimental validation or data generation guided by the model) and (**C**) the application category of the study. BD, model-driven discovery; BE, studies of evolutionary processes; II, interspecies interaction; ME, metabolic engineering; NA, analysis of network properties; PB, prediction of cellular phenotypes.](msb201318-f2){#f2}

![Six categories of uses and number of studies for each use of the *E. coli* metabolic GEM. The original five categories defined in 2008 ([@b31]) include (**A**) metabolic engineering, (**B**) model-driven discovery, (**C**) prediction of cellular phenotypes, (**D**) analysis of biological network properties and (**E**) studies of evolutionary processes. A new category has been added, (**F**) interspecies interaction. The addition of this category signifies a growing trend in the field to explore the interaction of the *E. coli* metabolic network with other organisms and across different environmental conditions. Specifically, studies have explored host/pathogen interactions ([@b46]), cocultures ([@b126]; [@b39]; [@b117]), ecology ([@b56]) and chemotaxis ([@b57]). The number of studies in this category is expected to increase, as the interest in understanding the complexities of microbial interactions and ecosystems continues to grow. The complete lists of the studies for each category are included in [Supplementary Table S1](#S1){ref-type="supplementary-material"}.](msb201318-f3){#f3}

![Iterative workflows. (**A**) A generic network reconstruction and model-driven systems biology workflow is a cyclic path that iterates between *in silico* predictions and *in vivo* observations. This general process has been followed in some of the more influential studies presented in this review. DNA sequencing and bibliomic data can be used to reconstruct and translate a biological system into a mathematical structure. Other omics data types that have been generated can be interpreted in the context of a reconstruction and computational model to analyze organism functions under specific conditions. This information becomes a *de facto* knowledge base that can be queried through a consortium of analytical methods. The aim of these methods is to hypothesize answers to complex biological questions that can often be nonintuitive or not readily apparent. Experiments can then be designed to test these predictions in order to either confirm GEM-derived explanations or move researchers one iteration closer to the answer. Studies that have successfully iterated through the *E. coli* GEM workflow that are presented as examples include (**B**) [@b95], (**C**) [@b105], (**D**) [@b129] and (**E**) [@b73].](msb201318-f4){#f4}

![The future of the *E. coli* GEM. The most widely used *E. coli* reconstruction accounts only for metabolism (the 'M\' matrix) ([@b30]). However, efforts are currently underway to integrate the operon structure that determines cellular regulation (the 'O\' matrix), the transcriptional and translational machinery allowing for the expression of proteins (the 'E\' matrix; [@b115]) and other cellular processes (e.g., DNA replication, posttranslational modifications, *etc*.) with metabolism. The integration of these cellular processes, supported by high-throughput data types, into a single mathematical model, will allow researchers to more accurately compute complex phenotypes, and will guide the discovery of unknown aspects of cellular functions beyond that of just metabolism.](msb201318-f5){#f5}

###### Strengths and limitations of the metabolic GEM applications

  Application                What the model can do                                                                                                            What the model cannot do
  -------------------------- -------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------
  Metabolic engineering      Gene deletion (combinatorial)                                                                                                    Limited coverage of molecular biology
                             Gene addition                                                                                                                    Predicting the effects of perturbations to regulatory elements
                             Gene over- and under-expression                                                                                                  Predicting allosteric inhibition
                             Rapidly test the systemic effects of heterologous pathway additions                                                              There is no explicit representation of metabolite concentrations
                             Design biomarkers/biosensors for characteristic function                                                                         Account for enzyme kinetics
                             Determine media supplementation strategiesMap high-throughput data to identify bottlenecks                                       Cannot accurately predict the performance of nonnative genes/proteins in *E. coli*
                             Design strains through evolution                                                                                                  
                                                                                                                                                               
  Biological discovery       Predict growth on different carbon sources/media conditions                                                                      Predict the regulation of isozymes/parallel pathways
                             Guide the functional assignment of network gaps                                                                                  Predict enzyme promiscuity
                             Guide the discovery of previously uncharacterized gene product functions (graph theory analysis)                                 Predictive power is inherently limited, because the model is not complete in scope
                             Guide the reannotations of incorrectly annotated genes                                                                           Predict the expression of genes
                             Connect orphan metabolites to known reactions                                                                                    Predict the functional state of proteins (e.g., posttranslational modification)
                                                                                                                                                               
  Phenotypic behavior        Predict optimal cellular behavior                                                                                                Differentiate between computed alternate optimal flux distributions of the cell *a priori*
                             Understand energetics and occurrence of suboptimal behavior                                                                      Explain the reasons for suboptimal performance *a priori*
                             Infer impact of regulationProvide a context for which experimental data can be interpreted                                       Provide a framework for incorporating additional regulatory interactions that are currently under development
                             Predict and understand absolute and conditional gene essentiality                                                                 
                             Predict and understand shifts in growth conditions                                                                                
                                                                                                                                                               
  Network analysis           Evaluate metabolic networks from a systems view through node and link dependencies, essentialities, overall network robustness   Does not always include the biological mechanisms behind the network connectionsFew predictions can be experimentally validated
                             Describe the complex interactions of the components of the metabolic network                                                      
                             Evaluate modularity of function                                                                                                   
                             Evaluate regulation based on network structure                                                                                    
                                                                                                                                                               
  Bacterial evolution        Predict essential genes                                                                                                          Account for changes in regulatory elements
                             Predict the endpoint of evolution                                                                                                Predict the time-course of evolution
                             Understand the basis for epistatic interactions and mutational effects                                                           Predict location of mutations in the genomePredict the effects of mutations in the genome
                             Provide insights into evolutionary trajectories                                                                                  Account for strain-specific genomic differences
                                                                                                                                                               
  Interspecies interaction   Model the exchange of metabolites                                                                                                Model interactions that affect metabolic regulation
                             Analyze high-throughput data from different strains                                                                              Inability to measure flux exchange in multi cell-type systems
                             Determine the cost/benefit ratio for different types of commensalism                                                             There are still too many unknowns to accurately build an interactions network
                                                                                                                                                              Limited ability to define individual genetic content in large communities
                                                                                                                                                              Limited spatial knowledge in large communities

###### Growth phenotyping

Growth phenotypes from single-gene deletion mutants based on *in silico* model predictions can be compared to *in vivo* experimental data to elucidate or confirm function of ORFs. The results of growth phenotyping studies can be classified into four categories: ·Growth/Growth (G/G): the model and experimental data show growth·Growth/No Growth (G/NG): the model predicts growth, but the experimental data indicates no growth·No Growth/Growth (NG/G): the model predicts no growth, but the experimental data indicates growth·Growth/No Growth (NG/NG): the model and experimental data show no growth.

The G/NG case indicates that the model over-estimates the metabolic capabilities of the organism, while the NG/G case indicates that the model under-estimates the metabolic capabilities of the organism. Metabolic over-predictions are commonly caused by reactions that are absent *in vivo*, reactions that are down-regulated or inhibited under a specific environmental condition, or the biomass formulation is includes an erroneous metabolite. Metabolic under-predictions often represent knowledge gaps in that the model does not account for an unknown isozyme, parallel pathway, or some other functionality of the organism. G/G can be regarded as a consistency check and NG/NG can be regarded as a form of model validation.

**Box 1 Figure** The four categories of growth phenotypes.

###### Microbial interactions

A microbial interaction can be defined and modeled as an exchange of molecules between species in a given environment. There are three main types of interaction classes between microbial species: Mutualism, also known as syntrophy or symbiosis, is where each organism produces an essential metabolite needed to support growth by the other organism.Commensalism is where only one organism depends on the other for the production of an essential nutrient to support growth. A special case of commensalism, known as parasitism, is when the organism providing the essential nutrient comes at the cost of reduced fitness. Host/pathogen interactions are a type of parasitism.Neutralism is where each organism can sustain growth in a given environment without the presence of the other organism. As each species are consuming the same resources, competition can arise between the organisms.

**Box 2 Figure** Microbial interactions as defined by metabolite exchange.
